Authors: Krisinda Clare C. Dim-Jamora, MD,1,2,3 Zharlah Gulmatico-Flores, MD, Stephen Lacson, MD, Ma.Cricelda Rescober-Valencia, MD, Francesca Sy-Alvarado, MD, Irene Gaile Robredo-Vitas, MD, Maria Cecilia Ingente-Tablante, MD, Teresita Ferrariz, MD, Agnes Thaebtharm, MD
Abstract
Introduction: Facial aesthetic injectables using soft tissue fillers and neurotoxins have been used for decades as part
of the armamentarium to enhance, restore, and attenuate aging skin.
Citation
–
Keywords
–
1. Avram M, Bertucci V, Cox SE, Jones D, Mariwalla K. American Society for Dermatologic Surgery Guidance Regarding SARS-CoV-2 mRNA Vaccine
Side Effects in Dermal Filler Patients December 29, 2020. Accessed January 19, 2021. https://www. asds.net/Portals/0/PDF/secure/ASDS-SARSCoV-2-Vaccine-Guidance.pdf.
2. Gotkin R; Gout U; Sattler S; Piansay-Soriano ES, Wanitphakdeedechka R, et al. Global Recommendations on COVID-19 Vaccines and Soft Tissue
Filler Reactions: A Survey-Based Investigation in Cooperation With the International Society for Dermatologic and Aesthetic Surgery (ISDS).
Journal of Drugs in Dermatology. 2021; Vol 20 Issue 4: 217-221. doi:10.36849/JDD.2021.6041.
3. ASPS Guidance Concerning FDA Reported Adverse Events in Patients with Dermal Fillers Receiving the SARS-CoV-2 mRNA Vaccine. https://
www.plasticsurgery.org/for-medical-professionals/covid19-member-resources/covid19-vaccine-dermal-fillers.
4. Guidance now includes information on the adenovirus vector Johnson & Johnson vaccine11-Mar-2021 10:30 AM EST, American College of
Allergy, Asthma and Immunology (ACAAI). https://www.newswise.com/coronavirus/acaai-updates-guidance-on-risk-of-allergic-reactionsto-covid-19-vaccines/?article_id=747642.
5. The Aesthetics Society: Facial Fillers and COVID-19 Vaccine. https://www.surgery.org/professionals/covid-19/facial-fillers-and-covid-19-
vaccine.
6. Mohammed G Turkmani, Koenraad De Boulle, Wolfgang G Philipp-Dormston. Delayed hypersensitivity reaction to hyaluronic acid dermal filler
following influenza-like illness Clin Cosmet Investig Dermatol. 2019; 12: 277–283. doi: 10.2147/CCID.S198081
More Articles
Syringocystadenoma papilliferum arising from a nevus sebaceus mimicking squamous cell carcinoma in a Filipino female: A case report
Authors: Maria Kristina R. Fajardo, MD, Daisy King-Ismael, MD, FPDS,Bernardita O. Policarpio, MD, FPDSAbstract INTRODUCTIONÂ :Syringocystadenoma papilliferum (SCAP) is a relatively rare benign adnexal skin tumor which can manifest in a variety of clinical forms. Nearly...
Drug-induced chronic bullous disease of childhood in a two-year-old Filipino male triggered by cefaclor or cefuroxime: A case report
Authors: Sher Claranza O. Liquido, MD, Maria Jasmin J. Jamora, MD, FPDSAbstract Introduction: N Chronic bullous disease of childhood (CBDC) is a rare immune-mediated subepidermal vesiculobullous eruption, characterized by linear IgA deposition along the basement...
Lupus panniculitis in an ANA-negative systemic lupus erythematosus patient: A case report
Authors: Ma. Corazon A. Iniego-Rodas, MD, DPDS, Maria Franchesca Quinio, MD, FPDS, DDSP-PDS, Charlene Ang-Tiu, MD, FPDSAbstract INTRODUCTIONÂ : Lupus panniculitis (LP) is an unusual type of cutaneous lupus erythematosus (CLE) wherein the cutaneous inflammatory reaction...